We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Demonstrates Latest Biochemistry, Immunology, POCT and Molecular Diagnostic Products

By LabMedica International staff writers
Posted on 12 Nov 2024

Tianlong Science and Technology (Shaanxi, China) is participating in the MEDICA 2024 exhibition where the company is showcasing its cutting-edge diagnostic solutions and latest products in biochemistry, immunology, POCT, and molecular diagnostics. More...

Among Tianlong’s innovations featuring at this year’s MEDICA is the Panall 8000 All-in-one Molecular Diagnosis system (Open system) that enables laboratories to program user-defined PCR analysis protocols. Laboratories can use user-defined protocols in addition to those developed by Tianlong. The simple and efficient design of the Panall 8000 allows labs to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents. Tianlong intends to bring more new tests to the Panall 8000 for detection of a broad range of disease categories.

Also featuring at MEDICA 2024 is the Gentier X3 Series Real-Time PCR System that features three independent thermal blocks, supporting users to run a maximum 3×32 well samples in three different protocols simultaneously. This can help labs save a lot of time and budget. With the powerful and efficient temperature control system, user-friendly operational designs, Tianlong Gentier X3 Series can provide maximal reliability and efficiency for all real-time PCR needs. Tianlong is also highlighting the Biolum Portable ATP Hygiene Monitoring System Pro which features an innovative design, making it a smartphone in the user’s hand. Featuring state-of-the-art technology, the new device can provide rapid and accurate data to support hygiene monitoring programs. Cloud-based data management enables users to monitor, track, and trend testing results across multiple facilities, making risk management easier than ever.

Additionally, Tianlong is presenting the V150 automatic chemiluminescence immunoassay analyzer designed for small and medium-sized laboratories, while also offering the capability for emergency testing in large hospitals and third-party laboratories. Alongside, Tianlong is highlighting the ZY-260 automatic clinical chemistry analyzer that uses concave grating photometry post-spectroscopic technology and has a constant speed of 200 tests/hour. The ZY-260 also features an AAA-supported system with improved traceability for ensuring the accuracy of results and has a high-capacity sample tray and reagent tray, allowing 72 clinical chemistry items to be run simultaneously.

Related Links:
Tianlong Science and Technology


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
New
Mini Vortex Mixer
Vornado
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.